Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
In vitro
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
In Vivo
Responsiveness to immunotherapies
PD-1/PD-L1 axis blockade
CTLA-4 blockade
Immunization
Syngeneic tumor models
Breast Cancer : 4T1
Breast Cancer : EMT6
Colon Cancer : CT26
Colon Cancer : MC38
Glioblastoma : GL261
Lung Cancer : Lewis LLC1
Pancreatic Cancer : Pan02
Renal Cancer : Renca
Sarcoma : MCA-205
Translational
Services
Custom tumor tissue sourcing
Target validation
Preclinical immune profiling
Biomarker discovery & testing
Image analysis
Technological platforms
Quantitative digital pathology
Digital spatial profiling
Whole-transcriptome spatial biology
Single-cell spatial transcriptomics
Single-cell RNA Seq
Proteomics
Flow cytometry
Featured service
TLS detection & evaluation
Spatial transcriptomics
Single-cell analysis
Spatial biology
About
About Explicyte
Science
News
Careers
Contact us
Toggle menu
Contact us
CRO Services
Explicyte Immuno-Oncology
>
CRO Services
View Details
Immune cell tumor killing
View Details
Antibody-dependent cell cytotoxicity (ADCC)
View Details
Macrophage assays
View Details
Mixed Lymphocyte Reaction (MLR)
View Details
Immune cell migration
View Details
Immune cell activation
View Details
Translational Research
View Details
In Vivo Models
View Details
Cell-based Assays
View Details
TLS-GC reaction
View Details
Image analysis for spatial biology
Previous page
1
2
3
4
WordPress Lightbox
